- Investing Ideas
- /
- Global Healthcare Undervalued Small Caps With Insider Buying
Global Healthcare Undervalued Small Caps With Insider Buying
Results
6
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
6 companies
CVS Group
Market Cap: UK£850.7m
Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia.
CVSG
UK£11.92
7D
5.5%
1Y
49.4%
Integra LifeSciences Holdings
Market Cap: US$972.1m
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$13.25
7D
16.0%
1Y
-44.1%
Cogstate
Market Cap: AU$446.2m
A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.
CGS
AU$2.60
7D
-1.9%
1Y
173.7%
Vimian Group
Market Cap: SEK 16.3b
Engages in the animal health business worldwide.
VIMIAN
SEK 30.96
7D
4.2%
1Y
-29.2%
Omda
Market Cap: NOK 953.6m
Provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally.
OMDA
NOK 46.50
7D
-1.1%
1Y
68.5%
RaySearch Laboratories
Market Cap: SEK 7.7b
A medical technology company, provides software solutions for cancer treatment worldwide.
RAY B
SEK 224.50
7D
1.8%
1Y
9.0%